1995 Volume 43 Issue Supplement4 Pages 277-279
We evaluated the clinical efficacy and safety of cefluprenam, a new injectable cephalosporin antibiotic. Cefluprenam was administered to 10 patients at a dose of 1.0 g twice daily for 7-21 days.Clinical response was good in 9 patients and fair in 1 patient.Adverse reactions were observed in two patients, and eosinophilia was observed in one patient.